F. Barry Bays, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 117,396 shares at $25.28 ($3.0M) on 2023-03-29, disclosed to the SEC on 2023-03-30.
Open-market sale of $3.0M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.02 | 26,241 | $657K | 22.2% |
| 2 | $25.02 | 26,241 | $657K | 22.2% |
| 3 | $25.28 | 32,457 | $821K | 27.8% |
| 4 | $25.28 | 32,457 | $821K | 27.8% |
| Total | $25.16 avg | 117,396 | $3.0M | 100% |
| Filing → |
| TMCI | SELL | 2023-04-13 | $4.5M | — | Filing → |
| TMCI | SELL | 2023-03-15 | $646K | — | Filing → |
| TMCI | SELL | 2023-02-23 | $615K | — | Filing → |